Close Menu

NEW YORK (GenomeWeb) – A study published today by researchers from the Karolinska Institute in Sweden has added robust new data on the ability of liquid biopsy to detect a range of tumor-associated genomic alterations in the blood of advanced prostate cancer patients.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.